Scott Hensley
Stories
-
Advisers to the FDA back COVID vaccines for the youngest children
A committee of experts voted unanimously to recommend that the Food and Drug Administration authorize COVID-19 vaccines from Moderna and Pfizer-BioNTech for children as young as 6-months-old.
-
All Things Considered
Advisers to FDA weigh in on updated COVID boosters for the fall
The vaccines now in use are based on the form of the virus that circulated at the beginning of the pandemic and are less effective against the omicron variant. New options are in the works.
-
Pfizer-BioNTech will seek authorization for second COVID booster for older adults
Pfizer and BioNTech are planning to ask the Food and Drug Administration to authorize a second COVID-19 booster shot for people age 65 and older.
-
FDA authorizes a Pfizer booster shot for children ages 12 to 15
The agency also shortened the time between the completion of primary vaccination of the Pfizer-BioNTech COVID-19 vaccine and a booster dose, down to five months from six.
-
The FDA has authorized Merck's COVID pill for home use — the second in two days
The medicine, called molnupiravir, is taken twice a day for five days and works by preventing the virus from replicating. Merck says it will have 10 million packs available by the end of the month.
-
FDA authorizes 1st antiviral pill for Covid
In a highly anticipated decision, the Food and Drug Administration authorized Pfizer's Paxlovid as the first antiviral pill to treat Covid-19 at home.
-
CDC advisers vote to narrow use of J&J vaccine due to concerns about rare blood clots
The recommendation was prompted by the occurrence of a rare and sometimes fatal blood clotting problem known as TTS. More than 16 million people in the U.S. have received a shot of the J&J vaccine.
-
Pfizer data shows that its COVID-19 pill is effective against severe disease
The research finds that the medicine, called Paxlovid, was effective in preventing hospitalization and death when taken by people with mild to moderate illness within a few days of symptoms.
-
An FDA panel supports Merck COVID drug in mixed vote
If the Food and Drug Administration authorizes use of the drug, called molnupiravir, it would be the first oral COVID-19 treatment that could be taken at home.
-
CDC advisers back expansion of COVID boosters for all adults
Hours after the Food and Drug Administration authorized booster doses of COVID-19 vaccine for all adults 18 years and older, a panel of experts endorsed their use with a few caveats.